NCT02413229 A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study Status COMPLETED Phase PHASE2
NCT02412644 Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT02368210 A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis (Study 306) Status COMPLETED Phase PHASE3
NCT02367911 A Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02346240 Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO) Status COMPLETED Phase PHASE3
NCT02340169 Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT02326298 An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) Status COMPLETED Phase PHASE3
NCT02326272 A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO) Status COMPLETED Phase PHASE3
NCT02310750 A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation Status COMPLETED Phase PHASE1
NCT02274792 Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis Status COMPLETED Phase PHASE4
NCT02243787 Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis Status TERMINATED Phase PHASE1/PHASE2
NCT02239666 Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis Status COMPLETED Phase N/A
NCT02201524 Study to Evaluate PF-04965842 in Patients With Moderate to Severe Psoriasis Status TERMINATED Phase PHASE2
NCT02192164 Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis Status COMPLETED Phase N/A
NCT02160665 Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT02153840 Clinical Trial of PSORI-CM01(YXBCM01) Granule to Treat Stable Plaque Psoriasis Status TERMINATED Phase NA
NCT02134210 Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Status COMPLETED Phase PHASE3